Chinese Pharmaceuticals have been sold off considerably in recent months, but look very attractive on a valuation basis. There are fundamental problems, but in light of China’s objective of universal health care coverage there is significant upside. See “Healthy Tigers” update in “Inside The Stock Market”.
Aug
04
2011
Asia Thematic Investing: Update On Healthy Tigers Index
Subscribe to Advisor Newsletter
Leuthold Advisors Newsletter subscriptions include a no-obligation 14-day trial. Cancel at any time before the 14 days are over and you will not be billed.
Subscribe nowLogin
For full access, please enter your credentials.
About The Author
